fbpx

Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?

Details
Category: Covid Health Resources
Created: Wednesday, 10 June 2020 22:50
Written by Chia Siang Kow and Syed Shahzad Hasan

Cartoon – The Birth of Big Pharma | HENRY KOTULAThe study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300529/

You must be logged in to comment due to spam issues.